Brand Name | Status | Last Update |
---|---|---|
idamycin pfs | New Drug Application | 2024-08-12 |
idarubicin hydrochloride | ANDA | 2025-01-07 |
Code | Description |
---|---|
J9211 | Injection, idarubicin hydrochloride, 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Drug common name | Idarubicin |
INN | idarubicin |
Description | Idarubicin is a monosaccharide derivative, an anthracycline antibiotic and a deoxy hexoside. It derives from a hydride of a tetracene. |
Classification | Small molecule |
Drug class | antineoplastic antibiotics (daunorubicin type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O |
PDB | — |
CAS-ID | 58957-92-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1117 |
ChEBI ID | 42068 |
PubChem CID | 42890 |
DrugBank | DB01177 |
UNII ID | ZRP63D75JW (ChemIDplus, GSRS) |